Clinical Trial Update: A 12-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Osteoarthritis Pain of the Knee [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating HP-5000 for osteoarthritis pain of the knee has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• HP-5000

Snippet

Sponsor: Noven Pharmaceuticals, Inc. | Conditions: Osteoarthritis Pain of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2025-09-04